Mercado de medicamentos recetados contra la obesidad: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00020942
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

INTRODUCCIÓN AL MERCADO La obesidad es un problema de salud pública y también una enfermedad metabólica genética y crónica que implica la acumulación excesiva o anormal de grasa en el cuerpo. Condiciones crónicas como hipertensión, enfermedades cardiovasculares, diabetes, insuficiencia ventilatoria, apnea obstructiva del sueño, cáncer y otras están asociadas con la obesidad. La creciente prevalencia de la obesidad entre niños y adultos es una amenaza para los países en desarrollo y también tiene un impacto importante en la longevidad de la población y los gastos relacionados con la salud. DINÁMICA DEL MERCADO Se espera que los cambios en el estilo de vida que conducen a una disminución en la práctica de ejercicio entre las personas, el desarrollo de productos y el aumento de la población obesa impulsen la demanda de medicamentos contra la obesidad en un futuro próximo. Sin embargo, se espera que la disponibilidad de terapias alternativas y los posibles efectos secundarios de los medicamentos contra la obesidad obstaculicen el crecimiento del mercado. ÁMBITO DEL MERCADO El "Análisis del mercado de medicamentos recetados contra la obesidad hasta 2031" es un estudio especializado y en profundidad de la industria de la salud con un enfoque especial en el análisis de tendencias del mercado global. El informe tiene como objetivo proporcionar una descripción general del mercado de medicamentos recetados contra la obesidad con una segmentación detallada del mercado por clase de medicamento, mecanismo de acción y canal de distribución. Se espera que el mercado de medicamentos recetados contra la obesidad experimente un alto crecimiento durante el período previsto. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores en el mercado de medicamentos recetados contra la obesidad y ofrece tendencias y oportunidades clave en el mercado. SEGMENTACIÓN DEL MERCADO El mercado de medicamentos recetados contra la obesidad está segmentado según la clase de medicamento, el mecanismo de acción y el canal de distribución. Según la clase de fármaco, el mercado se segmenta en bupropión y naltrexona, orlistat, lorcaserina, fentermina y topiramato, y liraglutida. Según el mecanismo de acción, el mercado se segmenta en fármacos de acción periférica y fármacos de acción central. Por canal de distribución, el mercado se segmenta en farmacia hospitalaria, farmacia minorista y farmacia online. El informe proporciona una descripción detallada de la industria que incluye información tanto cualitativa como cuantitativa. Proporciona una descripción general y una previsión del mercado de medicamentos recetados contra la obesidad en función de varios segmentos. También proporciona el tamaño del mercado y estimaciones de pronóstico del año 2021 al 2031 con respecto a cinco regiones principales, a saber; América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y América del Sur y Central. El mercado de medicamentos recetados contra la obesidad de cada región se subsegmenta posteriormente en los respectivos países y segmentos. El informe cubre el análisis y el pronóstico de 18 países a nivel mundial junto con las tendencias actuales y las oportunidades que prevalecen en la región. El informe analiza los factores que afectan el mercado de medicamentos recetados contra la obesidad tanto desde el lado de la oferta como de la demanda y evalúa en mayor profundidad la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, los impulsores, las restricciones, las oportunidades y las tendencias futuras. El informe también proporciona un análisis PEST exhaustivo para las cinco regiones, a saber; América del Norte, Europa, APAC, MEA y América del Sur y Central después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado de medicamentos recetados contra la obesidad en estas regiones. ACTORES DEL MERCADO El informe cubre desarrollos clave en el mercado de medicamentos recetados contra la obesidad como estrategias de crecimiento orgánico e inorgánico. Varias empresas se están centrando en estrategias de crecimiento orgánico como lanzamientos de productos, aprobaciones de productos y otros como patentes y eventos. Las estrategias de crecimiento inorgánico observadas en el mercado fueron adquisiciones, asociaciones y colaboraciones. Estas actividades han allanado el camino para la expansión de los negocios y la base de clientes de los actores del mercado. Se prevé que los actores del mercado de medicamentos recetados contra la obesidad tendrán oportunidades de crecimiento lucrativas en el futuro con la creciente demanda de medicamentos recetados contra la obesidad en el mercado global. A continuación se menciona la lista de algunas empresas que participan en el mercado de medicamentos recetados contra la obesidad. El informe también incluye los perfiles de actores clave en el mercado de medicamentos recetados contra la obesidad junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y clases de medicamentos, mecanismos de acción y canales de distribución ofrecidos, información financiera de los últimos 3 años y desarrollos clave en los últimos cinco años.
    •  BRISTOL-MYERS SQUIBB CO. •  TAKEDA FARMACÉUTICA •  EMPRESA EISAI •  GLAXOSMITHKLINE PLC •  PFIZER INC •  SHIONOGI USA INC •  VIVUS INC •  ZAFGEN INC •  NORGINE BV •  BOEHRINGER INGELHEIM GMBH.
El equipo dedicado de investigación y análisis de Insight Partner está formado por profesionales experimentados con conocimientos estadísticos avanzados y ofrece varias opciones de personalización en el estudio existente.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR in Anti-Obesity Prescription Drugs Market?

The market is expected to register a CAGR of 26% during 2021–2031.

What are driving factors impacting the Anti-Obesity Prescription Drugs Market?

The driving factors of the market are the global growth in obesity prevalence rates, developments in the formulation of effective drugs, and rising awareness about obesity-related diseases such as diabetes and heart problems.

What are the future trends of Anti-Obesity Prescription Drugs Market?

Key trends in the market include combination drugs, personalized weight loss medicines, and the increasing use of non-invasive treatments such as oral and injectable drugs.

Which are leading players in Anti-Obesity Prescription Drugs Market?

Key companies in this market are - Novo Nordisk (Saxenda), Eli Lilly (Wegovy), and Johnson & Johnson.

What are the deliverable formats of the Anti-Obesity Prescription Drugs Market?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. BRISTOL-MYERS SQUIBB CO.
2. TAKEDA PHARMACEUTICAL
3. EISAI COMPANY
4. GLAXOSMITHKLINE PLC
5. PFIZER INC
6. SHIONOGI USA INC
7. VIVUS INC
8. ZAFGEN INC
9. NORGINE BV
10. BOEHRINGER INGELHEIM GMBH.
11. 7TM PHARMA
12. ZYDUS CADILA
13. AKRIMAX PHARMACEUTICALS
14. ZEALAND PHARMA
15. ARROWHEAD RESEARCH

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.